CD8+ central memory T cells

Biomarker

3 papers2 findings

  • Human trial1
  • Humans1
  • Animals1

Associations

2

Remission

upin humans1OR 7.66

1 study
  1. CD8+ central memory T cells predict remission in humans (OR = 7.66, P = 0.03).

    “baseline levels of CD8+ Tcm cells showed the strongest predictive value in the TAU + ST group (OR = 7.66, P = 0.03)”

    Human trialin patients with MDD receiving adjunctive spinning therapy

    One treatment does not fit all: Indications that spinning therapy benefits only a subgroup of patients with depression characterized by a T memory cell inflation profile

    Brain, behavior, and immunity18 Dec 2025

Subclinical atherosclerotic plaque

upin humans1

1 study
  1. CD8+ central memory T cells are associated with subclinical atherosclerotic plaque in humans.

    “In contrast, CD8+ CM T-cells were found positively associated with SAP.”

    Humanshealthy older individualsn = 79

    Immunological biomarkers and molecular signatures in healthy aging: early dynamics of subclinical atherosclerosis in a homogeneous elderly cohort

    BMC cardiovascular disorders13 Oct 2025

More on Subclinical atherosclerotic plaque

Latest

Nov 2025: 1Dec 2025: 1Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 03 in 12 months